Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: The axtell regimen

C. F. Verschraegen, H. Arias-pulido, S. J. Lee, S. Movva, L. A. Cerilli, S. Eberhardt, B. Schmit, R. Quinn, C. Y. Muller, I. Rabinowitz, M. Purdy, D. Snyder, T. Bocklage

Research output: Contribution to journalArticlepeer-review

57 Scopus citations

Fingerprint

Dive into the research topics of 'Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: The axtell regimen'. Together they form a unique fingerprint.

Medicine & Life Sciences